Vehicle Safety
Recalls Search 320,000+ NHTSA safety recalls Complaints 2.1M+ consumer safety complaints TSBs 4.7M technical service bulletins VIN Lookup Decode any vehicle VIN instantly OBD Codes 12,000+ diagnostic trouble codes Fuel Economy EPA MPG data for all vehicles Safety Ratings 11,700+ NHTSA crash test ratings Investigations 5,300+ NHTSA defect investigations Statistics Recall trends & safety analysis
Consumer Safety
Product Safety 9,700+ CPSC product recalls Food Safety 28,600+ FDA food recalls Pet Safety 1.3M FDA animal adverse events Drug Safety 17,500+ FDA drug recalls Device Safety 38,400+ FDA device recalls Workplace Safety 102,900+ OSHA injury reports Brand History Cross-category recall lookup by company
Infrastructure
Bridge Safety 624,000 bridge inspections Aviation Safety 30,000+ NTSB aviation events Dam Safety 92,600 dam safety records Water Safety 433,000+ public water systems Railroad Safety 438,000+ rail crossings Pipeline Safety 8,800+ pipeline incidents State Safety Dashboards Safety grades for all 50 U.S. states ZIP Safety Report Check any 5-digit ZIP across 9 datasets
Public Health
Nursing Homes 14,700 CMS rated facilities Environmental 80,000+ hazardous sites & releases
Blog

Vehicle Safety

Vehicle Recalls320,000+ NHTSA safety recalls Browse VehiclesEvery make, model and year Complaints2.1M+ consumer safety complaints TSBs4.7M technical service bulletins VIN LookupDecode any vehicle VIN instantly OBD Codes12,000+ diagnostic trouble codes Fuel EconomyEPA MPG data for all vehicles Safety Ratings11,700+ NHTSA crash test ratings Investigations5,300+ NHTSA defect investigations StatisticsRecall trends & safety analysis Compare VehiclesTwo vehicles side by side

Consumer Safety

Product Safety9,700+ CPSC product recalls Food Safety28,600+ FDA food recalls Pet Safety1.3M FDA animal adverse events Drug Safety17,500+ FDA drug recalls Device Safety38,400+ FDA device recalls Workplace Safety102,900+ OSHA injury reports Brand HistoryRecall lookup by company

Infrastructure

Bridge Safety624,000 bridge inspections Aviation Safety30,000+ NTSB aviation events Dam Safety92,600 dam safety records Water Safety433,000+ public water systems Railroad Safety438,000+ rail crossings Pipeline Safety8,800+ pipeline incidents State DashboardsSafety grades for all 50 states ZIP ReportAny 5-digit ZIP across 9 datasets

Public Health

Nursing Homes14,700 CMS rated facilities Environmental80,000+ hazardous sites & releases BlogGuides, news & safety insights

Browse Drug Recalls

14,380 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 14,380 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 14,380 FDA drug recalls, Class II.

Clear
DateProductReasonClassFirm
Mar 20, 2026 Vancomycin HCI, 1.25 grams added to 250 mL, 0.9% Sodium Chloride Injection US... Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port Class II Fagron Compounding Services
Mar 20, 2026 Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP... Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port Class II Fagron Compounding Services
Mar 19, 2026 Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Syste... CGMP Deviations: use of an unapproved raw material Class II Teva Pharmaceuticals USA, Inc
Mar 19, 2026 Clonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Syste... CGMP Deviations: use of an unapproved raw material Class II Teva Pharmaceuticals USA, Inc
Mar 19, 2026 Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Syste... CGMP Deviations: use of an unapproved raw material Class II Teva Pharmaceuticals USA, Inc
Mar 19, 2026 traMADol Hydrochloride Tablets, USP, 50 mg, 500-count bottles, Rx only, Manu... Failed Impurities/Degradation Specifications: N-nitroso-desmethyl-tramadol impurity (NDSRI) was f... Class II Amneal Pharmaceuticals, LLC
Mar 17, 2026 Albuterol Sulfate Inhalation Solution, 0.5%, 25 mg/5 mL (5 mg/mL*), 30x5 mL S... Labelling: Illegible label Class II Nephron SC, LLC
Mar 17, 2026 Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx ... Failed Dissolution Specifications Class II Viatris, Inc.
Mar 17, 2026 CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-V... Lack of Assurance of Sterility Class II Chiesi USA, Inc.
Mar 17, 2026 Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, ... Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food ... Class II Teva Pharmaceuticals USA, Inc
Mar 17, 2026 Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, ... Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food ... Class II Teva Pharmaceuticals USA, Inc
Mar 17, 2026 Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, ... Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food ... Class II Teva Pharmaceuticals USA, Inc
Mar 16, 2026 Cinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle, Rx Only, Manu... CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit Class II Cipla USA, Inc.
Mar 16, 2026 Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manu... CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit Class II Cipla USA, Inc.
Mar 16, 2026 Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manu... CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit Class II Cipla USA, Inc.
Mar 16, 2026 Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60... Failed tablet specifications. Class II Amerisource Health Services LLC
Mar 13, 2026 Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, R... Presence of particulate matter: identified as Buprenorphine free base Class II ENDO USA, Inc.
Mar 13, 2026 Lanreotide Injection, 120 mg*/0.5 mL, Box contains 1 Pre-filled syringe and 1... Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for ... Class II Cipla USA, Inc.
Mar 13, 2026 Lanreotide Injection, 120 mg/0.5 mL, Box contains 1 Pre-filled syringe, Singl... Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for ... Class II Cipla USA, Inc.
Mar 11, 2026 0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL), 1,000 mL... Lack of Assurance of Sterility Class II Fresenius Kabi USA, LLC
Mar 11, 2026 0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 250 mL i... Lack of Assurance of Sterility Class II Fresenius Kabi USA, LLC
Mar 11, 2026 0.9% Sodium Chloride Injection, USP, 50 mL x60, Becton, Dickson and Company, ... Lack of Assurance of Sterility Class II Fresenius Kabi USA, LLC
Mar 11, 2026 0.9% Sodium Chloride Injection, USP 0.9% (450 mg per 50 mL) (9 mg per mL) 50 ... Lack of Assurance of Sterility Class II Fresenius Kabi USA, LLC
Mar 11, 2026 0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 1,000 mL... Lack of Assurance of Sterility Class II Fresenius Kabi USA, LLC
Mar 11, 2026 5% Dextrose Injection, USP 5 g per 100 mL (50 mg per mL) 100 mL in a 100 mL f... Lack of Assurance of Sterility Class II Fresenius Kabi USA, LLC
Mar 11, 2026 5% Dextrose Injection, USP 12.5 g per 250 mL (50 mg per mL) 250 mL in a 250 m... Lack of Assurance of Sterility Class II Fresenius Kabi USA, LLC
Mar 11, 2026 5% Dextrose Injection, USP 2.5 g per 50 mL (50 mg per mL) 50 mL in a 100 mL f... Lack of Assurance of Sterility Class II Fresenius Kabi USA, LLC
Mar 11, 2026 0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 100 mL i... Lack of Assurance of Sterility Class II Fresenius Kabi USA, LLC
Mar 11, 2026 0.9% Sodium Chloride Injection, USP, (4,500 mg per 500 mL) (9 mg per mL) 500 ... Lack of Assurance of Sterility Class II Fresenius Kabi USA, LLC
Mar 11, 2026 0.9% Sodium Chloride Injection, USP, 0.9% (900 mg per 100 mL) (9 mg per mL) 1... Lack of Assurance of Sterility Class II Fresenius Kabi USA, LLC
Mar 11, 2026 0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL) 500 mL in... Lack of Assurance of Sterility Class II Fresenius Kabi USA, LLC
Mar 11, 2026 0.45% Sodium Chloride Injection, USP, 1.125 grams per 250 mL (4.5 mg per mL),... Lack of Assurance of Sterility Class II Fresenius Kabi USA, LLC
Mar 11, 2026 0.9% Sodium Chloride Injection, USP, (2,250 mg per 250 mL) (9 mg per mL) 250 ... Lack of Assurance of Sterility Class II Fresenius Kabi USA, LLC
Mar 9, 2026 Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, Rx only, Manufactu... Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidiz... Class II Zydus Pharmaceuticals (USA) Inc
Mar 6, 2026 Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL ... Lack of Assurance of Sterility Class II PAYLESS COMPOUNDERS, LLC
Mar 5, 2026 Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx... Lack of Assurance of Sterility Class II Apotex Corp.
Mar 3, 2026 HydroPeptide CLEAR ALLIANCE SERUM, 2.5% BENZOYL PEROXIDE, a)1 FL OZ/30ml; b) ... Chemical contamination: Presence of benzene Class II Owen Biosciences Inc.
Mar 3, 2026 SLMD Benzoyl Peroxide Acne Lotion, Benzoyl Peroxide 2.5%, a) 0.7 fl. oz - 21 ... Chemical contamination: Presence of benzene Class II Owen Biosciences Inc.
Mar 3, 2026 SLMD BP Acne Spot Treatment, 10% Benzoyl Peroxide, 0.5 fl. oz - 15 mL bottles... Chemical contamination: Presence of benzene Class II Owen Biosciences Inc.
Mar 3, 2026 FHF Farmhouse Fresh, Midnight Clearing, NIGHT LOTION, 2.5% BENZOYL PEROXIDE A... Chemical contamination: Presence of benzene Class II Owen Biosciences Inc.
Mar 3, 2026 STERILE EYE DROPS SOOTHING TEARS (polyethylene glycol 400 0.4% and propylene ... Lack of Assurance of Sterility Class II K.C. Pharmaceuticals, Inc
Mar 3, 2026 Sterile EYE DROPS AC (tetrahydrozoline HCl 0.05%, zinc sulfate 0.25%), 0.5 fl... Lack of Assurance of Sterility Class II K.C. Pharmaceuticals, Inc
Mar 3, 2026 EYE DROPS Advanced Relief, (dextran 70 0.1%, polyethylene glycol 400 1% and t... Lack of Assurance of Sterility Class II K.C. Pharmaceuticals, Inc
Mar 3, 2026 Sterile EYE DROPS REDNESS LUBRICANT (glycerin 0.25% and naphazoline HCl 0.012... Lack of Assurance of Sterility Class II K.C. Pharmaceuticals, Inc
Mar 3, 2026 Dry Eye Relief Eye Drops, (glycerin 0.2%, hypromellose 0.2% and polyethylene ... Lack of Assurance of Sterility Class II K.C. Pharmaceuticals, Inc
Mar 3, 2026 Sterile Eye Drops ORIGINAL FORMULA (tetrahydrozoline HCl 0.05%), 0.5 FL OZ (1... Lack of Assurance of Sterility Class II K.C. Pharmaceuticals, Inc
Mar 3, 2026 Ultra Lubricating Eye Drops (polyethylene 400 0.4%, propylene glycol 0.3%), S... Lack of Assurance of Sterility Class II K.C. Pharmaceuticals, Inc
Mar 3, 2026 Artificial Tears Sterile Lubricant Eye Drops (polyvinyl alcohol 0.5%, povidon... Lack of Assurance of Sterility Class II K.C. Pharmaceuticals, Inc
Mar 3, 2026 Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx ... Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-... Class II Rising Pharma Holding, Inc.
Mar 2, 2026 Children's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) b... Presence of foreign substance: the firm received complaints for a gel-like mass and black particl... Class II STRIDES PHARMA INC

Frequently Asked Questions

When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.